文文 坡
赞了
$Ocugen(OCGN.US$
1. U.S. Phase 3 Bridging Study:
OCGN submitted an IND application to FDA on October 27, 2021, and FDA issued a Clinical Hold to OCGN on November 26, 2021. Currently, WE are waiting for the response from OCGN to FDA. The OCGN will receive a full response from the FDA on or after December 26, 2021. FDA will proceed with approval within 30 days of receiving OCGN's response.
1. U.S. Phase 3 Bridging Study:
OCGN submitted an IND application to FDA on October 27, 2021, and FDA issued a Clinical Hold to OCGN on November 26, 2021. Currently, WE are waiting for the response from OCGN to FDA. The OCGN will receive a full response from the FDA on or after December 26, 2021. FDA will proceed with approval within 30 days of receiving OCGN's response.
11
文文 坡
赞了
✅ 低于5美元的股票
BDR
EXPR
SOS
WORX
XELA
$Blonder Tongue Laboratories(BDR.US$ $Express, Inc.(EXPR.US$ $SOS Ltd(SOS.US$ $SCWorx(WORX.US$ $Exela Technologies(XELA.US$
BDR
EXPR
SOS
WORX
XELA
$Blonder Tongue Laboratories(BDR.US$ $Express, Inc.(EXPR.US$ $SOS Ltd(SOS.US$ $SCWorx(WORX.US$ $Exela Technologies(XELA.US$
已翻译
17
文文 坡
赞了
$Ardelyx(ARDX.US$ 空头将其浸泡这样他们就可以掩盖。只要它保持在1.45以上,它就会恢复到1.75
已翻译
22
61